sun pharma q2 revenue to be led by speciality biz & revlimid generic sales | cnbc tv18
Published 9 months ago • 247 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
4:45
sun pharma q2 results: profit rises 8% yoy to ₹ 2,260 crore as revenue jumps 14% | midcap radar
-
2:01
sun pharma to report its q2 results today, here is what expect | trading hour | cnbc-tv18
-
8:04
q2fy24 | sun pharma’s q2 revenue & net profit beat estimates | cnbc tv18
-
7:30
vanda pharmaceuticals vnda q2 2024 summary 02aug2024
-
6:39
sun pharma reports a largely in-line set of q4 numbers; us sales come in at $430 m | cnbc tv18
-
11:49
sun-ranbaxy: done deal
-
18:51
dilip shanghvi - sun pharma
-
6:23
exclusive: former ceo of ranbaxy on sun pharma buy out
-
3:56
sun pharma news: u.s. fda lists company's halol plant under an import alert | halftime report
-
1:31
bulls bet on these two big pharma stocks
-
2:09
what does sun pharma - ranbaxy deal entail for the 2 biggies?
-
11:02
sun-ranbaxy @ cci: 1st structural remedy!
-
3:44
the tale of two pharma companies: aurobindo shines, sun pharma coughs
-
2:50
healthcare is the way to reenter the market for the next 12 months, says bny's levine
-
0:55
ibis led phototherapy unit with dual rotatable heads with 12 blue leds 2 white leds each intensity
-
2:24
sun pharma to buy ranbaxy in $3.2 bn deal
-
4:48
sun pharma q3 results today: here're the key things to watch out for | bazaar corporate radar
-
0:54
sun pharma's q2 net profit rises 5%, meets estimates | bq prime
-
0:40
romsons intra flon iv cannula
-
2:07
addition of lenalidomide to patients with myeloma progressing on ruxolitinib and methylprednisolone